Opioid Use Disorder

Despite a slight decline in opioid prescription filling from 2016 to 2020, one-third of patients who had an electronic cardiac device implanted were given doses tied to increased risk for persistent use, researchers reported.

CHICAGO — Now more than ever, opioid use disorder must be treated by primary care physicians, according to Ann R. Garment, MD, FACP, a clinical associate professor at the NYU Grossman School of Medicine.

Communities with greater social vulnerability did not have greater geographic access to medication for opioid use disorder, according to a study published in JAMA Network Open.

Adults who previously used psilocybin, a psychedelic substance, were 30% less likely to have opioid use disorder, according to findings published in Scientific Reports.

Treatment with medications for opioid use disorder is associated with significant reductions in multiple modes of mortality for American veterans, according to a study published in the American Journal of Psychiatry.

Among Medicaid beneficiaries with opioid use disorder who were diagnosed with hepatitis C virus infection during pregnancy, less than 6% received care or medication within 6 months postpartum, according to data published in Obstetrics & Gynecology.

A mindfulness-based intervention was associated with significant reductions in chronic pain and opioid misuse compared with supportive psychotherapy, according to a recent study in JAMA Internal Medicine.

About one in four people who may have needed treatment for opioid use disorder received it in 2019, according to findings published in JAMA Network Open.

Pregnant women with opioid use disorder who had a psychiatric diagnosis were more likely to experience adverse maternal outcomes than those without a diagnosis, researchers reported.

The expansion of telehealth services during the COVID-19 pandemic allowed patients to remain in treatment for opioid use disorder, according to findings published in the Journal of Rural Mental Health.